REGULUS THERAPEUTICS INC. RGLS Cash Flow

Regulus therapeutics inc. (RGLS)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12
Operating activities
Net loss
-21,269	-18,592	-22,262	-27,112	-35,944	-48,709	-54,594	-60,149	-67,909	-71,905	-77,477	-81,169	-80,650	-81,836	-69,042	-62,522	-62,468	-55,748	-70,690	-67,488	-58,426	-56,680	-36,439	-28,805	-24,180	-18,668	0	0	0	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization expense
524	900	1,428	1,852	2,239	2,300	2,254	2,288	2,388	2,524	2,629	2,705	2,556	2,276	2,003	1,721	1,616	1,591	1,569	1,588	1,530	1,490	1,462	1,431	1,425	1,360	1,272	1,165	1,081	1,017	0	0	0
Loss from valuation of convertible note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,811	-14,543	-12,758	-11,805	-12,118	3,256	2,142	-1,508	-1,145	0	0	0	-	-	-	-
Stock-based compensation
2,152	2,288	2,883	3,735	4,773	5,441	5,485	5,379	6,888	7,642	9,950	12,133	11,504	12,872	13,214	12,382	16,014	15,368	13,936	12,928	8,742	7,039	5,608	4,959	4,035	3,422	3,342	2,778	2,224	1,550	0	0	0
Amortization of premium on investments, net
-	-	-	-	-	-148	-170	-255	-289	-349	-412	-488	-575	-666	-867	-1,030	-1,245	-1,472	-1,492	-1,522	-1,580	-1,597	-1,662	-1,668	-1,557	-1,439	0	0	0	-	-	-	-
Gain on reduction of lease liability
522	1,839	1,839	1,839	1,317	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
259	293	836	798	802	756	576	519	558	600	911	1,188	1,178	1,043	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of premium on investments, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Gain on investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Loss on disposal of long-term assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	-	0	0	-	-	-	-
Deferred income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-
Change in operating assets and liabilities:
Contracts and other receivables
-2,117	1,115	686	147	2,604	-347	-520	-506	-251	-1,284	247	547	377	-8,364	-39	-182	-2,682	9,746	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-
Prepaid materials
98	-270	87	-374	-374	-134	-1,343	-1,119	-1,182	-394	-353	4,047	2,869	616	4,673	1,452	1,719	3,460	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other assets
461	242	-152	-1,282	-1,136	-630	-1,014	-1,494	-1,768	-2,369	-2,261	-2,298	-2,217	778	1,342	2,673	3,277	683	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid and other current assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	876	1,133	634	308	0	0	0
Accounts payable
-1,620	-393	287	-3,865	-1,746	-4,029	-3,995	566	-81	-65	-463	1,429	886	3,123	2,512	1,186	964	529	494	-659	-108	940	1,501	1,872	2,293	860	492	268	-115	-189	0	0	0
Accrued liabilities
-885	-708	-705	-921	-1,627	-1,370	-978	-605	703	-492	-336	-622	-1,093	-871	-742	-1,428	599	2,094	1,595	1,603	1,494	556	1,114	2,607	494	1,355	758	177	1,039	-20	0	0	0
Accrued compensation
-1,383	75	-367	-395	798	-384	-395	-209	-189	-333	-603	-430	95	-74	291	-412	162	284	555	1,087	190	811	216	167	99	-51	255	233	254	677	0	0	0
Operating lease liabilities
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contract liabilities
-60	-2,572	-72	-72	-72	2,428	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,009	-2,739	-3,190	-3,090	-6,316	-4,466	-4,267	-5,039	-6,184	-10,718	-14,742	-16,819	-10,602	-1,044	407	486	0	0	0
Deferred rent
-	-	-	-	-	-1,252	-1,583	-1,494	-1,363	-1,068	-97	218	51	143	-300	-481	-213	-379	-336	-318	-300	-282	-282	-1,190	-138	-11	350	1,183	298	337	0	0	0
Other liabilities
-1,219	-1,895	-1,806	-2,338	-661	325	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-21,390	-19,821	-18,861	-25,586	-32,104	-43,273	-50,357	-50,577	-55,695	-58,773	-62,779	-66,614	-66,632	-56,882	-58,819	-55,119	-47,537	-49,859	0	0	0	-	-	-	-	-	-	-	0	-	0	0	0
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Investing activities
Purchases of short-term investments
-	-	-	-	-	-	-	-	-	55,686	52,933	39,332	46,900	65,110	72,053	62,351	61,719	78,401	128,213	111,397	110,794	113,417	73,883	100,322	93,711	72,005	103,144	74,950	75,503	62,041	0	0	0
Sales and maturities of short-term investments
-	-	-	-	-	46,541	51,732	59,163	60,600	69,941	78,260	91,794	89,595	101,387	106,332	99,183	103,868	101,306	98,758	84,946	86,059	85,421	78,505	68,751	58,893	31,951	25,053	32,622	24,402	33,083	0	0	0
Purchases of property and equipment
-	-	-	-	-	-	-	-	-	303	384	771	657	913	1,236	1,219	1,522	1,363	899	825	1,307	1,146	1,312	1,263	798	800	1,035	685	874	1,151	0	0	0
Sales of property and equipment
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales of property and equipment
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of intangibles
-	-	-	-	-	-	-	-	-	16	21	35	58	53	75	82	71	67	0	0	0	-	-	-	-	35	136	241	280	275	0	0	0
Net cash provided by investing activities
-87	74	6,573	19,642	35,241	46,519	44,477	7,751	7,015	13,936	24,922	51,656	41,980	35,311	32,968	35,531	40,556	21,475	0	0	0	-	-	-	-	-	-	-	0	-	0	0	0
Net cash provided by investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock, net
1	2,086	2,087	2,097	2,097	219	219	43,354	43,354	43,411	43,411	543	543	641	641	598	598	492	76,785	76,675	76,675	86,146	9,271	55,419	55,623	45,980	112,248	66,043	65,840	65,788	0	0	0
Principal payments on term loan
613	1,977	4,486	5,319	4,706	3,342	0	0	0	-	-	-	-	167	164	163	159	155	151	147	145	142	122	114	106	100	203	285	366	445	0	0	0
Proceeds from Stock Options Exercised
-	-	-	-	-	1	2	2	2	4	5	48	107	310	1,988	5,290	6,191	6,680	6,610	3,332	2,441	2,233	0	0	0	-	-	-	0	-	-	-	-
Proceeds from financing leases
-	-	-	-	-	-	-	-	492	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on financing leases
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on financing leases
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by financing activities
39,209	39,933	12,850	12,030	-2,874	-2,830	-258	43,773	43,848	43,415	43,373	456	20,292	20,552	22,233	25,544	6,630	7,017	0	0	0	-	-	-	-	-	-	-	0	-	0	0	0
Net decrease in cash and cash equivalents
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	947	-4,832	-1,422	5,516	-14,502	-4,360	-1,019	-3,618	5,956	-351	-21,367	8,366	11,060	11,124	19,520	-23,532	-9,146	-9,346	-22,745	16,064	14,242	7,726	31,377	0	0	0
Supplemental disclosure of cash flow information
Net changes in restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-1,256	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net changes in restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	0	0	-	0	0	1,441	-	523	66	24	27	31	33	36	39	0	0	0	-	-	-	-	8	0	0	0
Income taxes paid
-	-	-	-	-	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0	0	0	-	-	-	-	208	0	0	0
Supplemental disclosure of non-cash investing and financing activities
Non-cash acquisition of property and equipment
-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Allowance for tenant improvements
-	-	-	-	-	-	-	-	-	-	-	-	-	6,653	8,309	8,201	7,126	1,656	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash acquisition of property and equipment
-	-	-	-	-	-	-	-	-	-	-	181	215	292	58	354	295	223	255	49	-211	76	-57	12	7	0	0	0	0	-	-	-	-
Allowance for tenant improvements
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Amounts accrued for patent expenditures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-